Health Care · Industrial Inorganic Chemicals

VHI VALHI INC /DE/ SEC Filings & Insider Trading Activity 2026

company
CIK 5925586 filings
Russell 2000

VHI at a glance

VALHI INC /DE/ (VHI, SEC CIK 59255) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as May 22, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), VALHI INC /DE/ (VHI) reported revenue of $2.1 billion (down 1.3% from FY2024) and a net loss of $57.6 million. Diluted EPS was -$2.02.
  • As of September 30, 2026, 14 institutional investment managers tracked by SignalX reported holding VALHI INC /DE/ (VHI) shares worth $7.7 million in 13F-HR filings.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$2.1B
−1.3% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
14 funds
$7.7M · +0 vs prior quarter
Latest 8-K
Nov 5, 2026
Item 2.02 · Item 7.01

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business model: Manufacturing and selling component products (security and marine components) and real estate development, primarily in the U.S.
  • New strategic emphasis on mitigating tariff impacts by increasing electronic component purchases and implementing pricing adjustments in 2025
  • Shift in Real Estate segment focus due to sale of water utility assets and nearing completion of residential planned community development by end of 2027
  • Land sales revenue declined to $59.3M in 2025 from $71.5M in 2024 amid slowed development pace, yet operating income rose to $65.2M from $55.2M
  • Noteworthy pension plan settlement loss of $28.7M in Q4 2025 related to U.S. pension buy-out, significantly increasing net periodic pension expense for the year

Management Discussion & Analysis

  • Revenue $1.86B in 2025, down 1% YoY from $1.89B in 2024; Chemicals segment net sales decreased $27.7M (1%)
  • Chemicals segment operating loss $24.5M in 2025 vs operating income $138.5M in 2024; gross margin 11% vs 19%
  • Best performing segment: Real Estate Management and Development (positive impact from tax increment reimbursements $34.2M in 2025)
  • Worst performing segment: Chemicals with 2025 operating loss $24.5M vs income $138.5M in 2024, impacted by lower TiO2 prices and fixed costs
  • Cash flow: Not explicitly detailed, but restructuring charges $10.3M, pension plan settlement loss $28.7M, no buybacks/dividends/capex disclosed
  • 2026 outlook: Expect higher consolidated operating income driven by Chemicals segment due to higher sales volumes, selling prices, and lower costs; risks include economic uncertainty and geopolitical tensions

AI summary of the VHI 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No new risk factors disclosed, with Item 1A providing no material changes from the 2025 10-K
  • German tax assessments: 2019 through 2021 notices received in March 2026, with $2.0 million uncertain tax position recorded
  • Environmental liabilities: NLI remains exposed to CERCLA and other cleanup claims, including approximately five sites with unestimable costs
  • Chemicals market risk: segment sales concentrated in chemicals, representing $1,609.0 million of nine-month 2026 revenue
  • Debt and liquidity: Kronos carries €426.174 million of 9.50% notes due 2029, while Valhi had $119.7 million facility availability

Management Discussion & Analysis

  • Q3 net income $30.2M vs $22.2M loss YoY, driven by Chemicals operating income $60.5M vs $15.9M loss
  • Chemicals revenue $541.1M, up 18% YoY from $456.9M; gross margin 23% vs 10%
  • Component Products strongest segment: sales $44.0M vs $40.0M, operating income $6.4M vs $4.8M
  • Operating cash flow $71.7M through nine months vs $136.1M use; capital expenditures $42.9M
  • Outlook: 2026 sales, volumes and margins above 2025; headwinds include weak demand, tariffs and economic uncertainty

AI summary of the VHI 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 5, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q3 2026 net income $30.2M, or $1.06/share, versus $22.2M loss, or $0.78/share, in Q3 2025
  • Nine-month net income $54.5M, or $1.91/share, versus $4.4M loss, or $0.15/share, in 2025

Item 2.02: Results of Operations and Financial Condition

  • Item 2.02 contains no earnings release, financial results, or operating metrics for fiscal year 2026
  • No investor-actionable performance information appears in the provided filing section

Item 7.01: Regulation FD Disclosure

  • No substantive Regulation FD disclosure identified in the provided text

Item EX-99.2: Item EX-99.2

  • Quarterly dividend $0.08 per share declared by Valhi’s board
  • Payment scheduled for December 17, 2026
Filed Aug 6, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 results released August 6, 2026 through Exhibit 99.1
  • Financial performance details reside in the attached press release, not the 8-K narrative

Item 7.01: Regulation FD Disclosure

  • Valhi furnished an August 6, 2026 press release announcing a quarterly dividend
  • Dividend details and payment terms appear in Exhibit 99.2

Item EX-99.1: Item EX-99.1

  • Q2 net income attributable to Valhi stockholders surged to $22.3M, or $.78 per share, from $.9M, or $.03
  • Chemicals drove the improvement, with operating income rising to $40.4M from $10.3M despite lower TiO₂ pricing
Filed Jun 22, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Mary A. Tidlund resigning as Valhi director effective June 30, 2026
  • Resignation not related to disagreement with Valhi

AI summaries of VHI 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for VHI

Don't miss the next VHI filing

  • Alerts as it files. A push when VHI files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut VHI, by share count.
  • Ask anything. An AI agent that reads every VHI filing and answers with sources.

VHI alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Herrington TerriAMay 21, 2026$12.66
Norris Gina A.AMay 21, 2026$12.66
Hill Randy LAMay 21, 2026$12.66
Feehan Loretta J.AMay 21, 2026$12.66
Tidlund Mary A.AMay 21, 2026$12.66

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$2.1B$2.1B
Gross Profit-$424.5M$295.4M
Operating Income-$210.7M$63.3M
Net Income-$108.0M-$57.6M
Gross Margin-20.2%14.2%
Op. Margin-10.0%3.0%
Net Margin-5.1%-2.8%
Balance Sheet
Total Assets$2.7B$2.8B$2.6B
Equity$935.8M$1.0B$1.0B
ROE-10.4%-5.6%
Per Share
EPS-$3.79$-2.02
Cash Flow
Operating CF-$44.0M-$35.5M
CapEx-$30.9M$46.6M

Source: XBRL data in VALHI INC /DE/ (VHI)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate VHI share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
VHI shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202614$7.7M
Q2 202614$7.4M
Q1 202614$6.8M
Q4 202515$6.1M
Q3 202513$8.4M
Q2 202515$8.7M
Q1 202515$6.4M
Q4 202411$8.6M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 111 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

VHI filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 5, 2026Analysis-
10-QNov 5, 2026Analysis
10-QAug 6, 2026Analysis
8-KAug 6, 2026Analysis-
8-KJun 22, 2026Analysis-
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-
4May 22, 2026-
8-KMay 21, 2026Analysis
8-KMay 7, 2026Analysis
10-QMay 7, 2026Analysis
8-KMar 10, 2026Analysis-
10-KMar 10, 2026Analysis
8-KMar 5, 2026Analysis-
8-KDec 15, 2025-
10-QNov 6, 2025Analysis
10-QAug 7, 2025-
10-QMay 8, 2025-
10-KMar 6, 2025-
10-QNov 7, 2024-
10-QAug 8, 2024-
10-QMay 9, 2024-
10-KMar 7, 2024-

Related Health Care companies

All Health Care →

VHI SEC filings: frequently asked questions

Which institutions hold VHI stock?

As of September 30, 2026, the largest VALHI INC /DE/ (VHI) holders among the 13F filers tracked by SignalX were BlackRock ($2.9 million), Renaissance Technologies LLC ($1.9 million), BNY Mellon ($779,000), State Street Corp ($588,000), Northern Trust ($502,000). 13F-HR reports are filed up to 45 days after each quarter ends.

What was VHI's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), VALHI INC /DE/ (VHI) reported revenue of $2.1 billion (down 1.3% from FY2024) and a net loss of $57.6 million. Diluted EPS was -$2.02. The figures come from the XBRL data in the 10-K.

What did VHI report in its latest 8-K?

VALHI INC /DE/ (VHI) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Q3 2026 net income $30.2M, or $1.06/share, versus $22.2M loss, or $0.78/share, in Q3 2025.

What are the latest VHI SEC filings?

VALHI INC /DE/ (VHI) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on May 22, 2026.

What is VHI's SEC CIK number?

VALHI INC /DE/ (VHI)'s SEC Central Index Key (CIK) is 59255. EDGAR lists every VHI filing under that number.

Ask anything about VHI

The research agent reads VHI's filings, financials, insider trades and 13F holders, then answers with sources.